-
A quick search on pubmed finds 122 manuscripts published in the first half of 2011 that reference the Women's Health Initiative (WHI) study in the title, abstract, or as a keyword.
-
-
Two recent studies have re-energized discussion regarding the safety of ultrasound a subject that pops up periodically and then disappears until a new study surfaces.
-
Due to the frequent identification of metastatic disease at diagnosis and its high associated mortality, ovarian cancer has been the persistent focus of many screening efforts.
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
In this double-blind protocol, normal-weight (body mass index [BMI] 19.0-24.9 kg/m2) and obese (BMI 30.0-39.9 kg/m2) women with regular periods and normal ovarian ultrasound took one of two types of oral contraceptives (OCPs): either 21-day monophasic pills with 20 mcg ethinyl estradiol/100 mcg levonorgestrel or 30 mcg ethinyl estradiol/150 mcg levonorgestrel.
-
A California-based company is looking at new condom designs, including a male non-rolled silicone condom, a female silicone condom, and a silicone condom designed specifically for receptive anal intercourse.
-
Why is it so important that providers develop their skills when it comes to taking an adolescent sexual history?
-
Most adolescents who use contraception rely on combination oral contraceptive pills.
-
While only one company has received Food and Drug Administration (FDA) approval for an HIV home collection-test system that requires users to collect a blood specimen, then mail it to a laboratory for professional testing, no test kit is available to allow consumers to interpret test results at home.
